Multifaceted sentor (losartan) – basis for successful treatment of complex clinical cases
Versatility effects in hypertension angiotensin II receptor blocker losartan proved in many multi-center randomized trial. The experience of using Sentor (losartan) in Republic of Belarus among patients with arterial hypertension confirmed that this medicine is able to control and reduce the variability of blood pressure, to improve prognostic parameters, to act as a protection for organs, and, thus, to reduce the risk of cardiovascular complications and to improve the prognosis.